Last edition
News about
Renaissance Lakewood Expands New Jersey Lab Facilities
The facilities upgrade began in 2021 and consists of the relocation of existing labs from other parts of the Renaissance campus nearby to a new, 31,000-sq.-ft. science building and office space.
Zydus Gets EIR for Injectables Manufacturing Facility at Zydus Biotech Park, Ahmedabad
The inspection was a cGMP Inspection and had ended with NIL observations.
Nitika Pharmaceuticals to Inaugurate Microcrystalline Cellulose Manufacturing Plant in Nagpur
Nitika Pharmaceuticals Specialties to unveil India’s largest Microcrystalline Cellulose manufacturing plant. This event will be graced by two distinguished leaders, Nitin Gadkari and Devendra Fadnavis.
The companies had entered a partnership in February 2022 to build the largest cGMP facility, for full ecosystem microbiome therapies in Europe.
The Global Antibiotic Research & Development Partnership (GARDP) and India-based Orchid Pharma Ltd (Orchid) have signed a sublicense agreement to manufacture cefiderocol, an antibiotic to treat certain Gram-negative infections.
JB Pharma Publishes its 2nd Sustainability (ESG) Report
The report reflects JB Pharma’s priorities in building sustainable, equitable and resilient systems to promulgate good health for the current and future generations.
Bormioli Pharma Launches 'Plastic Academy'
Bormioli Pharma is launching the Plastic Academy, a training project designed to launch young talents into the profession of plastics processing technician.
AI will Alter All Drug Development Processes by 2026, Says CPHI Annual Report
The CPHI Report’s AI findings, which are released ahead of CPHI Barcelona held at Fira Barcelona (October 24-26th, 2023), point to the technology having a transformational impact on all parts of drug discovery and development within the next 24-months.
Gufic Biosciences Ltd Receives TGA Australia and ANVISA Brazil Approval for Parecoxib 40mg Injection
Gufic has been persistently committed to saving and improving lives of patients across the globe with its continuous efforts through the international regulatory agencies to bring novel molecules for the mankind.
Mirum Pharmaceuticals Announces the Appointment of Eric Bjerkholt as CFO
Bjerkholt brings extensive business leadership experience from roles served in the biopharmaceutical industry. He comes to Mirum from Chinook Therapeutics, Inc., where he served as CFO overseeing financial reporting, planning and budgeting, internal controls, investor relations, facilities, and information technology functions.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy